IL33 and neoplasm: In a mouse model of GC, mast cells were proved to be the major effector cells of IL-33 and could promote GC by recruiting macrophages; the frequencies of ILC2s and Tregs were comparable between tumor and normal tissues regardless of ST2 deficiency in mice (63).